Meridian Bioscience Inc.
VIVO
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.42M
Close$
$35.10
944.7% upside
Current Fair Value
944.7% upsideUndervalued by 944.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $56.42 Million |
|---|---|
| Enterprise Value | $14.56 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $- |
| Beta | -0.65 |
| Outstanding Shares | - |
Return
| Return on Equity | -0.79% |
|---|---|
| Return on Assets | -0.59% |
| Return on Invested Capital | 6.90% |
Valuation & Multiples
| P/E Ratio | 3.48 |
|---|---|
| PEG | -1.18 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | 0.56 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 2.21 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
February 12, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Meridian Bioscience Inc.
CEO: John Kenny